MedTrace Logo

Effects of Low-density Lipoprotein (LDL) Apheresis on Inflammatory and Lipid Markers

NCT01138371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2013-12-17

No results posted yet for this study

Summary

The primary objective of this study is to measure how LDL apheresis affects levels of inflammatory and cholesterol markers in human beings. The investigators will address this question by drawing pre- and post-LDL apheresis blood from patients who are undergoing this procedure. A secondary objective of this study is to learn how specific inflammatory markers behave in our blood in terms of time to rebound back to normal levels. The investigators will address this question by drawing post-LDL apheresis blood at predetermined time intervals.

Conditions

  • Familial Hypercholesterolemia

Interventions

PROCEDURE

LDL Apheresis

LDL Apheresis

Sponsors & Collaborators

  • Kaneka Medical America LLC

    collaborator INDUSTRY

  • Emory University

    lead OTHER

Principal Investigators

  • Laurence Sperling, MD · Emory University

  • Vimal Ramjee, MD · Emory University

Eligibility

Min Age
3 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01138371 on ClinicalTrials.gov